These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 35384875)
1. Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing Analysis. Pan CC; Tseng CE; Kuroda N; Yano M; Yasuda M; Nagashima Y; Yeh YC; Wang YC; Chang YH; Epstein JI Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):257-263. PubMed ID: 35384875 [TBL] [Abstract][Full Text] [Related]
2. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status. Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863 [TBL] [Abstract][Full Text] [Related]
3. [Molecular features of metanephric adenoma and their values in differential diagnosis]. Wang X; Shi SS; Yang WR; Ye SB; Li R; Ma HH; Zhang RS; Lu ZF; Zhou XJ; Rao Q Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):38-42. PubMed ID: 28072975 [No Abstract] [Full Text] [Related]
4. [Clinicopathological features of adult Wilms tumor with BRAF V600E mutation]. Gan HL; Wang QF; Zhu XL; Lyu H; Wang J Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036 [No Abstract] [Full Text] [Related]
8. Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms' tumor. Yin X; Zhang X; Pan X; Tan J; Zheng L; Zhou Q; Chen N Front Oncol; 2022; 12():1020456. PubMed ID: 36313688 [TBL] [Abstract][Full Text] [Related]
9. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma. Argani P; Tickoo SK; Matoso A; Pratilas CA; Mehra R; Tretiakova M; Sibony M; Meeker AK; Lin MT; Reuter VE; Epstein JI; Gagan J; Palsgrove DN Am J Surg Pathol; 2022 Jul; 46(7):988-999. PubMed ID: 35184066 [TBL] [Abstract][Full Text] [Related]
10. BRAF mutations in metanephric adenoma of the kidney. Choueiri TK; Cheville J; Palescandolo E; Fay AP; Kantoff PW; Atkins MB; McKenney JK; Brown V; Lampron ME; Zhou M; Hirsch MS; Signoretti S Eur Urol; 2012 Nov; 62(5):917-22. PubMed ID: 22727996 [TBL] [Abstract][Full Text] [Related]
11. BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children's Oncology Group Study AREN03B2. Goldstein JA; Renfro LA; Jennings LJ; Mullen EA; Geller J; Vallance K; Fernandez CV; Perlman EJ Arch Pathol Lab Med; 2024 Oct; 148(10):e362-e366. PubMed ID: 38116848 [TBL] [Abstract][Full Text] [Related]
12. Paediatric metanephric tumours: a clinicopathological and molecular characterisation. de Jel DVC; Hol JA; Ooms AHAG; de Krijger RR; Jongmans MCJ; Littooij AS; Drost J; van Grotel M; van den Heuvel-Eibrink MM Crit Rev Oncol Hematol; 2020 Jun; 150():102970. PubMed ID: 32371339 [TBL] [Abstract][Full Text] [Related]
13. Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma. Udager AM; Pan J; Magers MJ; Palapattu GS; Morgan TM; Montgomery JS; Weizer AZ; Hafez KS; Miller DC; Wolf JS; McHugh JB; Chinnaiyan AM; Dhanasekaran SM; Mehra R Am J Surg Pathol; 2015 Apr; 39(4):549-57. PubMed ID: 25602792 [TBL] [Abstract][Full Text] [Related]
14. Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process. Lenci N; Francesco P; Scarciglia E; Fiorentino V; Schino M; Palermo G; Racioppi M; Bassi P; Martini M Med Mol Morphol; 2021 Jun; 54(2):187-191. PubMed ID: 33175195 [TBL] [Abstract][Full Text] [Related]
15. Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases. Ding Y; Wang C; Li X; Jiang Y; Mei P; Huang W; Song G; Wang J; Ping G; Hu R; Miao C; He X; Chen G; Li H; Zhu Y; Zhang Z Diagn Pathol; 2018 Aug; 13(1):54. PubMed ID: 30111351 [TBL] [Abstract][Full Text] [Related]
16. BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition. Obasaju P; Shahab S; Dunn E; Rhee DS; Jiang L; Dome JS; Friedman AD; Argani P; Pratilas CA Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238401 [TBL] [Abstract][Full Text] [Related]
17. BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors. Marsden L; Jennings LJ; Gadd S; Yu M; Perlman EJ; Cajaiba MM Hum Pathol; 2017 Feb; 60():32-36. PubMed ID: 27769870 [TBL] [Abstract][Full Text] [Related]
18. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation? Dadone B; Ambrosetti D; Carpentier X; Duranton-Tanneur V; Burel-Vandenbos F; Amiel J; Pedeutour F Cancer Genet; 2013; 206(9-10):347-52. PubMed ID: 24432405 [TBL] [Abstract][Full Text] [Related]
19. Metanephric adenoma vs. Wilms' tumor: a report of 2 cases with diagnosis by fine needle aspiration and cytologic comparisons. Khayyata S; Grignon DJ; Aulicino MR; Al-Abbadi MA Acta Cytol; 2007; 51(3):464-7. PubMed ID: 17536557 [TBL] [Abstract][Full Text] [Related]
20. Metanephric adenoma: molecular study and review of the literature. Rodríguez-Zarco E; Machuca-Aguado J; Macías-García L; Vallejo-Benítez A; Ríos-Martín JJ Oncotarget; 2022; 13():387-392. PubMed ID: 35198098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]